Greek Drug Pricing Proposal Slammed

24 February 1997

In Greece, a proposal that wholesale prices of pharmaceuticals be fixedat 63% of the average level in all other European Union countries has been attacked by local producers and importers.

The proposal, submitted to the Ministry of Commerce by the Committee for Price Readjustment, goes on to say that with a single invoicing system in operation, prices of locally-made drugs should also be set at this level.

Industry representatives say that adoption of this plan would not only inflict grave damage on the domestic industry but also seriously harm the national drug supply, as overseas manufacturers would hardly be keen to sell their products in Greece at prices so much lower than elsewhere in the EU. One industry spokesman asked, not entirely seriously, if the plan were to be extended to all other imports, so that foreign producers of cars, stereos, fuels, etc would also be asked to supply their products to Greek buyers at prices 37% lower than in the rest of Europe.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight